세계의 인공뼈 시장 :재료 유형, 기술, 제품 유형, 용도, 최종 사용자별 예측(2025-2030년)

The Artificial Bone Market was valued at USD 1.61 billion in 2023, expected to reach USD 1.70 billion in 2024, and is projected to grow at a CAGR of 5.60%, to USD 2.37 billion by 2030.

The artificial bone market is defined by its focus on biomaterials used to replace or repair damaged bone tissues in medical procedures. These materials, which include ceramics, polymers, and composites, mimic the properties of natural bones and are essential for orthopedics, dental surgeries, and spinal procedures. The necessity for artificial bones is underpinned by an aging global population, rising incidences of bone degeneration diseases, and increased accident-related injuries, which amplify the demand for innovative bone repair solutions. Applications extend across vertebral fusion, fracture repair, and bone implants in orthopedic and dental sectors, driving growth from both an application and end-use perspective, including hospitals, clinics, and specialized surgical centers.

Market insights reveal several factors influencing growth, such as advancements in material science, growing healthcare expenditure, and heightened awareness about treatment alternatives. However, the market faces limitations like high development costs, stringent regulatory frameworks, and biocompatibility issues, which can impede the pace of innovation. The competitive landscape encourages continuous research into biodegradable and osteoconductive materials, with particular focus on enhancing biointegration. Emerging economies provide significant growth opportunities due to increased healthcare infrastructure investment and a growing middle-class population demanding improved medical services.

Recommendations for capitalizing on these opportunities include leveraging strategic partnerships with research institutions, prioritizing custom solutions adapted to patient-specific needs, and investing in R&D for next-generation biomaterials like 3D-printed bones and nanotechnology-infused composites. Nevertheless, the market's nature, characterized by rapid technological shifts and regulatory changes, underscores the importance of agile adaptation to market dynamics. Businesses must navigate these challenges by fostering collaboration across the supply chain and ensuring compliance with evolving standards to sustain long-term growth. In summary, focusing on innovation, regulatory compliance, and market-specific strategies can help businesses optimally position themselves in the evolving artificial bone market landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Artificial Bone Market

The Artificial Bone Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of orthopedic diseases and rising aging population globally
  • Increasing awareness and acceptance of artificial bone grafts among patients and healthcare providers
  • Government initiatives and funding for healthcare and biomedical research
• Market Restraints
  • Risks associated with artificial bone grafts, such as infections and graft rejection
• Market Opportunities
  • Integration of digital health technologies such as smart sensors in artificial bones
  • Development of personalized artificial bone products with advances in 3D printing and custom-made solutions
  • Increasing investment in research and development for bio-compatible and longer-lasting artificial bone materials
• Market Challenges
  • Lack of awareness and expertise among healthcare professionals about advancements in artificial bone technologies
  • Challenges in integrating artificial bone solutions with existing medical infrastructure and treatment protocols

Porter's Five Forces: A Strategic Tool for Navigating the Artificial Bone Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Artificial Bone Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Artificial Bone Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Artificial Bone Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Artificial Bone Market

A detailed market share analysis in the Artificial Bone Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Artificial Bone Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Artificial Bone Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Artificial Bone Market

A strategic analysis of the Artificial Bone Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Artificial Bone Market, highlighting leading vendors and their innovative profiles. These include Advanced Medical Solutions Group plc, Aesculap, Inc., Allosource, B. Braun Melsungen AG by Octane Medical Group, Bando Chemical Industries Ltd., baxter International, Inc., Bioventus LLC, Bone Biologics Corp, ConforMIS, Inc. by restor3d, curasan AG, Exactech, Inc., Globus Medical, Inc., Graftys SA, Integra LifeSciences Holdings Corporation, Johnson &Johnson, Medtronic plc, NovaBone by Halma PLC, NuVasive, Inc., Orthofix Medical Inc., OssDsign AB, Ossur hf., RTI Surgical Holdings, Inc., Smith & Nephew plc, Stryker Corporation, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Artificial Bone Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Material Type, market is studied across Ceramics, Composites, Metallic, and Polymers. The Ceramics is further studied across Calcium Phosphate Ceramics and Zirconia-Based Ceramics. The Composites is further studied across Metal-Ceramic Composites and Polymer-Ceramic Composites. The Metallic is further studied across Stainless Steel-Based Alloys and Titanium-Based Alloys. The Polymers is further studied across Biodegradable Polymers and Non-Biodegradable Polymers.
• Based on Technology, market is studied across 3D Printing, Bioprinting, Nanotechnology, and Plasma Spraying.
• Based on Product Type, market is studied across Bone Morphogenetic Protein (BMP), Demineralized Bone Matrix (DBM), Stem Cell-Based Bone Grafts, and Synthetic Bone Grafts.
• Based on Application, market is studied across Craniomaxillofacial, Dental, Joint Reconstruction, Orthopedic Surgery, Spinal Surgery, and Trauma.
• Based on End User, market is studied across Ambulatory Surgical Centers, Hospitals, Research and Academic Institutions, and Specialty Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of orthopedic diseases and rising aging population globally
    • 5.1.1.2. Increasing awareness and acceptance of artificial bone grafts among patients and healthcare providers
    • 5.1.1.3. Government initiatives and funding for healthcare and biomedical research
  • 5.1.2. Restraints
    • 5.1.2.1. Risks associated with artificial bone grafts, such as infections and graft rejection
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of digital health technologies such as smart sensors in artificial bones
    • 5.1.3.2. Development of personalized artificial bone products with advances in 3D printing and custom-made solutions
    • 5.1.3.3. Increasing investment in research and development for bio-compatible and longer-lasting artificial bone materials
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of awareness and expertise among healthcare professionals about advancements in artificial bone technologies
    • 5.1.4.2. Challenges in integrating artificial bone solutions with existing medical infrastructure and treatment protocols
• 5.2. Market Segmentation Analysis
  • 5.2.1. Application: Increasing demand for artificial bone in joint reconstruction to replace or support deteriorated joints
  • 5.2.2. Material Type: Increasing utilization of calcium phosphate ceramics material in bone grafts
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Artificial Bone Market, by Material Type

• 6.1. Introduction
• 6.2. Ceramics
  • 6.2.1. Calcium Phosphate Ceramics
  • 6.2.2. Zirconia-Based Ceramics
• 6.3. Composites
  • 6.3.1. Metal-Ceramic Composites
  • 6.3.2. Polymer-Ceramic Composites
• 6.4. Metallic
  • 6.4.1. Stainless Steel-Based Alloys
  • 6.4.2. Titanium-Based Alloys
• 6.5. Polymers
  • 6.5.1. Biodegradable Polymers
  • 6.5.2. Non-Biodegradable Polymers

7. Artificial Bone Market, by Technology

• 7.1. Introduction
• 7.2. 3D Printing
• 7.3. Bioprinting
• 7.4. Nanotechnology
• 7.5. Plasma Spraying

8. Artificial Bone Market, by Product Type

• 8.1. Introduction
• 8.2. Bone Morphogenetic Protein (BMP)
• 8.3. Demineralized Bone Matrix (DBM)
• 8.4. Stem Cell-Based Bone Grafts
• 8.5. Synthetic Bone Grafts

9. Artificial Bone Market, by Application

• 9.1. Introduction
• 9.2. Craniomaxillofacial
• 9.3. Dental
• 9.4. Joint Reconstruction
• 9.5. Orthopedic Surgery
• 9.6. Spinal Surgery
• 9.7. Trauma

10. Artificial Bone Market, by End User

• 10.1. Introduction
• 10.2. Ambulatory Surgical Centers
• 10.3. Hospitals
• 10.4. Research and Academic Institutions
• 10.5. Specialty Clinics

11. Americas Artificial Bone Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Artificial Bone Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Artificial Bone Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. AstraZeneca completes USD 1.05 billion acquisition of Amolyt Pharma
  • 14.3.2. SIIF Impact Capital invests in ORTHOREBIRTH's innovative ReBOSSIS to improve elderly bone fracture care
  • 14.3.3. Vinmec Hospital performs groundbreaking surgery using 3D-printed artificial bones
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Advanced Medical Solutions Group plc
• 2. Aesculap, Inc.
• 3. Allosource
• 4. B. Braun Melsungen AG by Octane Medical Group
• 5. Bando Chemical Industries Ltd.
• 6. baxter International, Inc.
• 7. Bioventus LLC
• 8. Bone Biologics Corp
• 9. ConforMIS, Inc. by restor3d
• 10. curasan AG
• 11. Exactech, Inc.
• 12. Globus Medical, Inc.
• 13. Graftys SA
• 14. Integra LifeSciences Holdings Corporation
• 15. Johnson &Johnson
• 16. Medtronic plc
• 17. NovaBone by Halma PLC
• 18. NuVasive, Inc.
• 19. Orthofix Medical Inc.
• 20. OssDsign AB
• 21. Ossur hf.
• 22. RTI Surgical Holdings, Inc.
• 23. Smith & Nephew plc
• 24. Stryker Corporation
• 25. Zimmer Biomet Holdings, Inc.